Talks Break Down
0.0%
A less likely outcome is that negotiations fail because investors cannot agree on control rights, data access, valuation, or risk-sharing terms. Given the size of the proposed raise, a breakdown would be a negative signal for late-stage AI-biotech financing.
What it moves
- Healthcare−0.5%
- Technology−0.3%
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.